Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
Opravil M, Hirschel B, Lazzarin A, Furrer H, Chave JP, Yerly S, Bisset LR, Fischer M, Vernazza P, Bernasconi E, Battegay M, Ledergerber B, Günthard H, Howe C, Weber R, Perrin L; Swiss HIV Cohort Study. Opravil M, et al. Among authors: chave jp. J Infect Dis. 2002 May 1;185(9):1251-60. doi: 10.1086/340312. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 12001042 Free article. Clinical Trial.
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine.
Sudre P, Chave JP, Ruef C, Iten A, Bucher HC, Vernazza PL, Furrer H, Bernasconi E, Ceserani N, Battegay M, Von Overbeck J, Cassis I, Lazzarin A, Gabriel V, Hirschel BJ; The Swiss HIV Cohort Study. Sudre P, et al. Among authors: chave jp. Clin Microbiol Infect. 1997 Feb;3(6):629-633. doi: 10.1111/j.1469-0691.1997.tb00469.x. Clin Microbiol Infect. 1997. PMID: 11864204 Free article.
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.
Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A, Hirschel B, Boggian K, Chave JP, Opravil M, Weber R, Rickenbach M, Telenti A; Swiss HIV Cohort Study. Bernasconi E, et al. Among authors: chave jp. J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):50-5. doi: 10.1097/00126334-200209010-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12352150
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.
Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A; Swiss HIV Cohort Study. Fellay J, et al. Among authors: chave jp. Lancet. 2002 Jan 5;359(9300):30-6. doi: 10.1016/S0140-6736(02)07276-8. Lancet. 2002. PMID: 11809184
Infrequent transmission of HIV-1 drug-resistant variants.
Yerly S, Jost S, Telenti A, Flepp M, Kaiser L, Chave JP, Vernazza P, Battegay M, Furrer H, Chanzy B, Burgisser P, Rickenbach M, Gebhardt M, Bernard MC, Perneger T, Hirschel B, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. Among authors: chave jp. Antivir Ther. 2004 Jun;9(3):375-84. Antivir Ther. 2004. PMID: 15259900
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.
Kouyos RD, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, Schanz M, Liechti T, Friedrich N, Braun DL, Scherrer AU, Weber J, Uhr T, Baumann NS, Leemann C, Kuster H, Chave JP, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Metzner KJ, Günthard HF, Trkola A; Swiss HIV Cohort Study. Kouyos RD, et al. Among authors: chave jp. Nature. 2018 Sep;561(7723):406-410. doi: 10.1038/s41586-018-0517-0. Epub 2018 Sep 10. Nature. 2018. PMID: 30202088
91 results